Aerotab Non-Aspirin

Description

AEROTAB is a non-aspirin formulation containing acetaminophen at a dosage of 500 mg per unit. It serves as both a fever reducer and a pain reliever, effectively alleviating various aches. Each packet contains two tablets, designed for convenient dosing.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with various conditions, including the common cold, headache, toothache, muscular aches, backache, arthritis, and menstrual cramps. Additionally, it is indicated for the temporary reduction of fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Patients should adhere strictly to the prescribed dosage and administration guidelines. The maximum dosage for adults and children aged 12 years and older is 2 tablets every 4 to 6 hours, not to exceed 8 tablets within a 24-hour period. This medication should not be used for more than 10 consecutive days unless specifically directed by a healthcare professional.

For children under 12 years of age, this extra strength product is contraindicated, as it may lead to an overdose and result in serious health complications. It is imperative that healthcare providers counsel patients on the importance of following these guidelines to avoid potential adverse effects.

Contraindications

Use of this product is contraindicated in patients with a known allergy to acetaminophen. Additionally, concurrent use with any other medication containing acetaminophen, whether prescription or nonprescription, is contraindicated due to the risk of acetaminophen overdose.

Warnings and Precautions

Severe liver damage may occur with the use of this product, which contains acetaminophen, under the following circumstances: if an adult consumes more than 4000 mg of acetaminophen within a 24-hour period, if it is taken concurrently with other medications containing acetaminophen, or if the individual consumes three or more alcoholic drinks daily while using this product.

Acetaminophen may also lead to severe skin reactions, which can manifest as skin reddening, blisters, or rash. In the event of any skin reaction, it is imperative to discontinue use immediately and seek medical assistance.

Healthcare professionals should advise patients to consult a doctor prior to use if they have a history of liver disease. Additionally, it is recommended that patients taking the anticoagulant warfarin consult with a healthcare provider or pharmacist before using this product.

In cases of accidental overdose, immediate medical attention is crucial. Patients should contact a doctor or the Poison Control Center at 1-800-222-1222 without delay, even if no signs or symptoms are apparent.

Patients are instructed to discontinue use and consult a doctor if any of the following occur: symptoms do not improve, pain worsens or persists for more than 10 days, fever intensifies or lasts longer than 3 days, new symptoms arise, redness or swelling is observed, or if a rare sensitivity reaction occurs.

Side Effects

Severe liver damage may occur in patients taking this product containing acetaminophen if they exceed 4000 mg in a 24-hour period, use it in conjunction with other medications containing acetaminophen, or consume three or more alcoholic drinks daily while using this product.

Patients may also experience severe skin reactions associated with acetaminophen, which can manifest as skin reddening, blisters, or rash. In the event of a skin reaction, it is imperative that patients discontinue use and seek medical assistance immediately.

Patients are advised to stop use and consult a healthcare professional if symptoms do not improve, if pain worsens or persists for more than 10 days, if fever intensifies or lasts longer than 3 days, if new symptoms arise, if redness or swelling occurs, or if a rare sensitivity reaction is suspected.

Prior to using this product, patients with liver disease should consult a healthcare provider. Additionally, patients taking the blood-thinning medication warfarin should seek advice from a doctor or pharmacist before use.

Drug Interactions

Patients taking warfarin, a blood-thinning medication, should consult a healthcare professional prior to using this drug. The interaction may increase the risk of bleeding due to potential alterations in coagulation parameters.

Additionally, concurrent use with any other medication containing acetaminophen, whether prescription or nonprescription, is contraindicated. This combination may elevate the risk of hepatotoxicity. It is advisable to monitor for signs of liver dysfunction and to avoid exceeding the recommended dosage of acetaminophen from all sources.

Packaging & NDC

Below are the non-prescription pack sizes of Aerotab Non-Aspirin (acetaminophen 500mg es). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should not use this extra strength product, as it may result in doses exceeding the recommended amount, potentially leading to serious health complications. For adolescents aged 12 years and older, the recommended dosage is 2 tablets every 4 to 6 hours. Careful adherence to these guidelines is essential to ensure safety and efficacy in this population.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment should be closely monitored when using this product, which contains acetaminophen. It is important to note that severe liver damage may occur under certain conditions. Specifically, patients should not exceed 4000 mg of acetaminophen in a 24-hour period. Additionally, caution is advised if the product is taken concurrently with other medications containing acetaminophen, as this may increase the risk of liver injury.

Furthermore, patients who consume three or more alcoholic drinks daily while using this product are at an elevated risk for liver damage. Therefore, it is recommended that healthcare providers assess liver function and consider dosage adjustments or alternative therapies for patients with compromised liver function to mitigate these risks. Regular monitoring of liver enzymes may be warranted in these patients to ensure safety and efficacy.

Overdosage

In cases of overdosage, significant health risks are associated with the consumption of acetaminophen.

Risk of Severe Liver Damage Administration of acetaminophen exceeding 4000 mg within a 24-hour period in adults can lead to severe liver damage. This risk is further compounded when acetaminophen is taken concurrently with other medications that also contain this active ingredient.

Additionally, individuals who consume three or more alcoholic beverages daily while using acetaminophen are at an increased risk for severe liver damage.

Recommended Actions Healthcare professionals should monitor patients for symptoms of liver injury, which may include nausea, vomiting, loss of appetite, confusion, jaundice, and abdominal pain. In the event of suspected overdosage, immediate medical intervention is critical.

Management may involve the administration of N-acetylcysteine (NAC) as an antidote, particularly if the overdose is identified within a specified time frame post-ingestion. Continuous assessment of liver function tests is advised to evaluate the extent of liver damage and guide further treatment.

Prompt recognition and management of acetaminophen overdosage are essential to mitigate the risk of severe hepatic injury.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

Postmarketing experience has identified that acetaminophen may be associated with severe skin reactions. Reported symptoms include skin reddening, blisters, and rash. In the event of a skin reaction, it is advised to discontinue use immediately and seek medical assistance.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of an accidental overdose, patients should be instructed to contact a doctor or the Poison Control Center at 1-800-222-1222 immediately, as prompt medical attention is crucial for both adults and children, even if no signs or symptoms are apparent.

Patients should be cautioned against using the medication if they have a known allergy to acetaminophen. Additionally, they should not use this medication in conjunction with any other products containing acetaminophen, whether prescription or nonprescription. If patients are uncertain whether a drug contains acetaminophen, they should be encouraged to consult with a doctor or pharmacist for clarification.

Patients should be informed to discontinue use and seek medical advice if their symptoms do not improve, if pain worsens or persists for more than 10 days, or if fever intensifies or lasts longer than 3 days. They should also be advised to stop use and consult a doctor if new symptoms arise, if there is any redness or swelling, or if they experience a rare sensitivity reaction.

Furthermore, patients should be prompted to consult a doctor before using the medication if they have liver disease. It is also important to recommend that patients speak with a doctor or pharmacist before using this medication if they are currently taking the blood-thinning medication warfarin.

Storage and Handling

The product is supplied in tamper-evident packaging. It is essential to inspect the packaging prior to use; do not utilize the product if the packet is torn, cut, or opened.

For optimal storage, the product should be maintained at a temperature range of 20°-25°C (68°-77°F). Proper adherence to these storage conditions is crucial to ensure the integrity and efficacy of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Aerotab Non-Aspirin, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)